In contrast, the association between high PRSS2 expression and favorable prognosis in PTC suggests that its oncogenic role may not be straightforwardly evident in the context of PTC, and that its biological function might be influenced by the specific tumor microenvironment and pathological state. This evidence concerns the gene PRSS2 and neoplasm.